The weekly litigation news digest is live. Subscribe now

IP Verse

Uniqure Biopharma competitive analysis

Loading summary...

Latest patents of Uniqure Biopharma opposed by its competitors

Explore Uniqure Biopharma's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Nov 20, 2025
Patent NumberPublication DateTitleTotal Oppositions
EP4032979
May 1, 2024Factor Ix Polypeptide Mutant, Its Uses And A Method For Its Production1
EP3581650
Dec 28, 2022Factor Ix Polypeptide Mutant, Its Uses And A Method For Its Production1
EP2337849
Jun 13, 2018Factor Ix Polypeptide Mutant, Its Uses And A Method For Its Production5

Latest PTAB cases involving Uniqure Biopharma

Discover the latest PTAB cases involving Uniqure Biopharma, highlighting their recent legal challenges and patent disputes.

Last updated on: Nov 22, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Uniqure Biopharma

IPR2021-00925May 11, 2021PFIZERUNIQURE BIOPHARMAFinal Written Decision
IPR2021-00926May 11, 2021PFIZERUNIQURE BIOPHARMAFinal Written Decision
IPR2021-00928May 11, 2021PFIZERUNIQURE BIOPHARMAFinal Written Decision
IPR2020-00388Jan 4, 2020PFIZERUNIQURE BIOPHARMAFinal Written Decision

Peer Comparison New

IP litigation analysis comparing Uniqure Biopharma with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 20, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
UNIQURE BIOPHARMA - 7 - 4
BAXALTA520 - -
GREAVES BREWSTER9 - - -
PFIZER51944312